ArticleSleep & breathing = Schlaf & Atmung2025
Patent foramen ovale (PFO) exacerbates intermittent hypoxia in moderate-to-severe obstructive sleep apnea (OSA) patients.
Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeBoth obstructive sleep apnea (OSA)and patent foramen ovale (PFO) can lead to changes in blood oxygen. However, it is unclear whether PFO exacerbates the blood oxygen indicators of OSA.
methodsThis case series study included patients who underwent contrast-enhanced transcranial Doppler (c-TCD) and polysomnography (PSG examination) between January 2017 to December 2023 at the Third Affiliated Hospital of Yan'an University. Based on c-TCD and PSG results, patients were categorized into two groups: OSA and PFO double-positive group (OSA + PFO), OSA single-positive group (OSA). Furthermore, both the OSA + PFO and OSA groups were further subdivided into mild (5 times/hour ≤ AHI < 15 times/hour), moderate (15 times/hour ≤ AHI < 30 times/hour) and severe (AHI ≥ 30 times/hour) groups according to their apnea-hypopnea index (AHI). This study compared the minimum oxygen saturation, oxygen desaturation index (ODI), the percentage of cumulative time with oxygen saturation < 90% in total sleep time (T90) among all groups.
resultsA total of 509 patients were included (386 males,75.83%; 123females,24.17%), with an average age of 56.76 ± 10.23 years. The study cohort included 97 OSA + PFO cases (55.67% moderate to severe) and 412 OSA cases (63.35% moderate to severe). No significant differences were observed in minimum oxygen saturation (75.97 ± 12.70% vs. 76.34 ± 12.67%, respectively, P =0.607) and ODI (32.99 ± 24.16% vs. 34.31 ± 23.59%, respectively, P =0.173) between the OSA group and the OSA + PFO group. Similarly, no significant differences were found in T90 (14.20 ± 20.50% vs. 16.69 ± 21.62%, respectively, P =0.075) between the OSA group and the OSA + PFO group. However, the T90 values were significantly higher in the moderate-severe OSA + PFO group compared to the moderate-severe OSA group (26.21 ± 22.97% vs.18.68 ± 22.02%, respectively, P < 0.05).
conclusionsAlthough PFO has no significant effect on minimum oxygen saturation and ODI, PFO further aggravates intermittent hypoxia in patients with moderate to severe OSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.